On Sunday Patently Apple posted a report titled "A California Jury is now deliberating on whether Apple infringed Masimo's smartwatch technology." With a California judge dismissing two key claims from Masimo, the jury was left with one decision: Did Apple improperly use Masimo's trade secrets for the Apple Watch blood-oxygen monitoring sensor.

Late yesterday, the jury in the trial failed to reach a unanimous verdict. Jurors in federal court in Santa Ana, California, told the judge Monday they were unable to reach a consensus, with six out of seven panelists voting to clear the iPhone maker of wrongdoing.

“We’re not going to be able to come to a joint conclusion,” the all-female panel wrote in its final note to the judge. Earlier, the jury said six of its members voted for Apple and one for Masimo, and she refused to change her mind. US District Judge James Selna declared a mistrial late Monday afternoon.

It’s unusual for jurors to report on a vote in their closed-door deliberations as judges routinely warn them against doing so.

Masimo shares dropped as much as 5.3% in after-hours trading after the jurors reported their vote before rebounding when the mistrial was declared.

In his closing argument, Apple’s lawyer, Joe Mueller, invited the employees one by one to stand, repeating over and over they “told you the truth.”

After the mistrial was declared Apple thanked the jury in a statement.

 “We deeply respect intellectual property and innovation and do not take or use confidential information from other companies,” the company said. “We are pleased that the court correctly rejected half of the plaintiffs’ trade secret allegations, and will now ask the court to dismiss the remaining claims.” For more, read the full Bloomberg report.